Linxin Liu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical outcomes of long-term infliximab treatment for 15 years in patients with Crohn's disease: a retrospective study.
Journal: Expert opinion on biological therapy
Published: February 20, 2026
Comparative effectiveness of ustekinumab versus infliximab in the management of perianal fistulizing Crohn's disease: a retrospective study in China.
Journal: Intestinal research
Published: October 16, 2024
Bacteroides uniformis ameliorates pro-inflammatory diet-exacerbated colitis by targeting endoplasmic reticulum stress-mediated ferroptosis.
Journal: Journal of advanced research
Published: August 26, 2024
Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn's disease.
Journal: Therapeutic advances in gastroenterology
Published: August 08, 2024
Acidity-induced ITGB6 promote migration and invasion of lung cancer cells by epithelial-mesenchymal transition and focal adhesion.
Journal: Experimental cell research
Published: October 25, 2023
miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis.
Journal: Acta pharmaceutica Sinica. B
Published: February 28, 2021
Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 27, 2018
Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization.
Journal: International journal of cancer
Published: November 08, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026